Prince Pharmaceutical Co., Ltd. (TPEX:6935)

Prince Pharmaceutical Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	690.03	753.33	712.53	441.08	295.79
Revenue Growth (YoY)	-8.40%	5.73%	61.54%	49.12%	18.50%
Cost of Revenue	615.75	600.23	506.74	315.59	206.82
Gross Profit	74.28	153.09	205.79	125.49	88.98
Selling, General & Admin	75.43	72.74	65.9	47.38	61.15
Research & Development	48.2	54.67	72.05	79.21	78.22
Operating Expenses	123.63	127.31	138.03	126.6	139.26
Operating Income	-49.35	25.78	67.76	-1.11	-50.28
Interest Expense	-10.27	-10.46	-8.94	-7.55	-5.31
Interest & Investment Income	1.3	1.16	0.22	0.03	0.17
Currency Exchange Gain (Loss)	-	-	4.18	-1	-0.8
Other Non Operating Income (Expenses)	6.38	2.63	0.92	-0.76	15.02
EBT Excluding Unusual Items	-51.95	19.11	64.14	-10.4	-41.2
Gain (Loss) on Sale of Assets	-0.14	0.06	0.06	0.09	-0.25
Pretax Income	-52.08	19.17	64.2	-10.31	-41.44
Income Tax Expense	1.46	3.86	12.65	-2.01	-7.64
Net Income	-53.54	15.31	51.55	-8.3	-33.8
Net Income to Common	-53.54	15.31	51.55	-8.3	-33.8
Net Income Growth	-	-70.30%	-	-	-
Shares Outstanding (Basic)	37	36	33	33	33
Shares Outstanding (Diluted)	37	37	33	33	33
Shares Change (YoY)	0.09%	9.66%	0.41%	1.45%	2.07%
EPS (Basic)	-1.46	0.43	1.55	-0.25	-1.03
EPS (Diluted)	-1.46	0.42	1.55	-0.25	-1.03
EPS Growth	-	-72.90%	-	-	-
Free Cash Flow	28.21	0.45	72.13	1.38	-186.73
Free Cash Flow Per Share	0.77	0.01	2.16	0.04	-5.71
Dividend Per Share	-	0.250	0.150	-	-
Dividend Growth	-	66.67%	-	-	-
Gross Margin	10.76%	20.32%	28.88%	28.45%	30.08%
Operating Margin	-7.15%	3.42%	9.51%	-0.25%	-17.00%
Profit Margin	-7.76%	2.03%	7.23%	-1.88%	-11.43%
Free Cash Flow Margin	4.09%	0.06%	10.12%	0.31%	-63.13%
EBITDA	4.54	75.94	113.7	40.05	-26.52
EBITDA Margin	0.66%	10.08%	15.96%	9.08%	-8.96%
D&A For EBITDA	53.89	50.16	45.93	41.16	23.76
EBIT	-49.35	25.78	67.76	-1.11	-50.28
EBIT Margin	-7.15%	3.42%	9.51%	-0.25%	-17.00%
Effective Tax Rate	-	20.12%	19.70%	-	-

Updated Aug 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.